Breaking News Instant updates and real-time market news.

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11

Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation

According to a post on the FDA's website, Amgen's treatment of Acute Myeloid Leukemia was granted orphan designation. Reference Link

AMGN Amgen
$188.31

1.6 (0.86%)

02/01/19
PIPR
02/01/19
NO CHANGE
PIPR
Overweight
Amgen acquisition of Alexion could make a lot of sense, says Piper Jaffray
While most investors anticipate Amgen (AMGN) could be shopping for smaller, bolt-on deals amid increased investor and press speculation that it is now an active acquirer, a larger deal with more near-term accretion potential may make more sense, Piper Jaffray analyst Christopher Raymond tells investors in a research note partially titled "Go Big or Go Home?" He thinks a potential Amgen for Alexion Pharmaceuticals (ALXN) deal "could actually make a lot of sense." Even at levels approaching $200 per share for Alexion, Amgen "could make a strong argument for a business combination," says Raymond. Alexion closed yesterday up $1.64 to $122.96. The analyst admits that some "bolt-on deals have been bandied around" by investors that "arguably make sense" for Amgen, including Biohaven Pharmaceutical and Amarin (AMRN). However, none of these options on their own get Amgen "to where they need to be to address the growth challenges of the legacy franchises," Raymond argues. He thinks a better deal for the company may be Alexion, which would bring in a "long-tailed asset" with Soliris/Ultomiris, an area Amgen has already approached with its Soliris biosimilar effort. The analyst's math has the potential deal being accretive next year, growing to 20%-plus accretion by 2024 for Amgen, even at a takeout price approaching $200 per Alexion share. Raymond keeps Overweight ratings on both companies.
01/30/19
HCWC
01/30/19
NO CHANGE
Target $281
HCWC
Buy
Amgen, Novartis reports show Ligand assets 'looking good,' says H.C. Wainwright
This morning, Ligand Pharmaceuticals (LGND) partner Novartis (NVS) reported Promacta Q4 revenue of $330M, above H.C. Wainwright analyst Joseph Pantginis' estimate of $306M. Promacta has now hit its first year of blockbuster status with 2018 sales of $1.174B, which is an important feat in the face of new competition, Pantginis tells investors in a research note. The analyst believes Ligand's increasing royalty revenue streams and growing number of deals that result in milestones "effectively refute the bear thesis we've seen in a few other firms' freely accessible research." With Amgen (AMGN) reporting Q4 Kyprolis revenue of $251M, the analyst says Ligand's top assets are "looking good." He reiterates a Buy rating on the shares with a $281 price target.
01/30/19
LEER
01/30/19
NO CHANGE
Target $192
LEER
Market Perform
Amgen price target lowered to $192 from $200 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Amgen to $192 from $200 after reporting Q4 results that beat consensus estimates for revenue and earnings, but with the company's guidance for revenue to decline by 4%-8% in 2019 and for EPS to be flat to down, despite a mid-single digit share count decline after its large share buyback in 2018. The analyst reiterates a Market Perform rating on the stock.
01/29/19
PIPR
01/29/19
NO CHANGE
Target $210
PIPR
Overweight
Amgen price target lowered to $210 from $220 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond lowered his price target on Amgen to $210 after its disappointing FY19 earnings guidance and the higher than anticipated operating expenses for Q4. The analyst also keeps his Overweight rating, noting that its management has a "track record for conservativism with respect to initial guidance" and also citing its impressive launch of Aimovig along with the strong performance by Sensipar and Neulasta.

TODAY'S FREE FLY STORIES

BHB

Bar Harbor Bankshares

$24.04

-0.31 (-1.27%)

16:56
03/21/19
03/21
16:56
03/21/19
16:56
Hot Stocks
Bar Harbor Bankshares authorizes stock repurchase plan of up to 5% »

Bar Harbor Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

16:55
03/21/19
03/21
16:55
03/21/19
16:55
Conference/Events
BMW management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

SMAR

Smartsheet

$45.60

-0.03 (-0.07%)

16:54
03/21/19
03/21
16:54
03/21/19
16:54
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

BA

Boeing

$372.69

-3.72 (-0.99%)

, LMT

Lockheed Martin

$298.95

3.04 (1.03%)

16:50
03/21/19
03/21
16:50
03/21/19
16:50
Hot Stocks
Sikorsky-Boeing helicopter achieves first flight »

The Sikorsky-Boeing…

BA

Boeing

$372.69

-3.72 (-0.99%)

LMT

Lockheed Martin

$298.95

3.04 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 28

    May

VOYA

Voya Financial

$50.34

0.11 (0.22%)

16:50
03/21/19
03/21
16:50
03/21/19
16:50
Conference/Events
Voya Financial management to meet with Evercore ISI »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 23

    May

BIIB

Biogen

$226.71

-93.76 (-29.26%)

, AAPL

Apple

$195.07

6.93 (3.68%)

16:48
03/21/19
03/21
16:48
03/21/19
16:48
On The Fly
Fly Intel: Wall Street's top stories for Thursday »

Stocks did not show much…

BIIB

Biogen

$226.71

-93.76 (-29.26%)

AAPL

Apple

$195.07

6.93 (3.68%)

MU

Micron

$44.00

3.92 (9.78%)

F

Ford

$8.69

0.18 (2.12%)

AMZN

Amazon.com

$1,818.45

21.09 (1.17%)

SNAP

Snap

$11.02

0.08 (0.73%)

LEVI

Levi Strauss

$22.42

(0.00%)

WMT

Walmart

$99.05

0.4 (0.41%)

SRNE

Sorrento Therapeutics

$5.20

1.71 (49.00%)

DRI

Darden

$116.11

7.485 (6.89%)

DXCM

DexCom

$142.13

-3.94 (-2.70%)

CSIQ

Canadian Solar

$19.27

-4.27 (-18.14%)

GES

Guess

$19.33

-2.77 (-12.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 16

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 21

    Mar

GG

Goldcorp

$11.17

0.13 (1.18%)

, NEM

Newmont Mining

$34.32

0.44 (1.30%)

16:47
03/21/19
03/21
16:47
03/21/19
16:47
Hot Stocks
Paulson & Co. opposes terms of Newmont's proposed acquisition of Goldcorp »

Paulson & Co, a…

GG

Goldcorp

$11.17

0.13 (1.18%)

NEM

Newmont Mining

$34.32

0.44 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

CBAN

Colony Bankcorp

$16.70

-0.04 (-0.24%)

16:45
03/21/19
03/21
16:45
03/21/19
16:45
Hot Stocks
LBC shareholders approve merger with Colony Bankcorp »

Colony Bankcorp, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:42
03/21/19
03/21
16:42
03/21/19
16:42
Conference/Events
CLSA Asia consumer analyst to hold a group luncheon »

Head of Asia Consumer…

16:38
03/21/19
03/21
16:38
03/21/19
16:38
Conference/Events
CLSA Asia gaming analyst to hold a group luncheon »

Jonathan Galligan, Head…

16:37
03/21/19
03/21
16:37
03/21/19
16:37
General news
Fed Balance Sheet Level data reported »

Week of 3/20 Fed Balance…

EXPE

Expedia

$124.13

1.56 (1.27%)

16:37
03/21/19
03/21
16:37
03/21/19
16:37
Hot Stocks
Expedia says Scott Rudin resigned from board »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$335.02

4.31 (1.30%)

16:37
03/21/19
03/21
16:37
03/21/19
16:37
Hot Stocks
Ulta Beauty director Dennis Eck sells 15K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$45.60

-0.03 (-0.07%)

16:35
03/21/19
03/21
16:35
03/21/19
16:35
Initiation
Smartsheet initiated at DA Davidson »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

KVHI

KVH Industries

$10.71

-0.11 (-1.02%)

16:35
03/21/19
03/21
16:35
03/21/19
16:35
Hot Stocks
KVH Industries expands HTS Maritime Network for entire Pacific Ocean region »

KVH Industries announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLW

Clearwater Paper

$21.20

-0.135 (-0.63%)

, ITRI

Itron

$51.15

0.64 (1.27%)

16:32
03/21/19
03/21
16:32
03/21/19
16:32
Hot Stocks
Clearwater Paper names Robert Hrivnak as CFO, succeeding John Hertz »

Clearwater Paper (CLW)…

CLW

Clearwater Paper

$21.20

-0.135 (-0.63%)

ITRI

Itron

$51.15

0.64 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$18.77

-0.24 (-1.26%)

16:32
03/21/19
03/21
16:32
03/21/19
16:32
Initiation
Stifel starts Amarin with Buy rating, sees 'robust' growth for Vascepa »

Stifel analyst Derek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

MTW

Manitowoc

$17.11

0.1 (0.59%)

16:31
03/21/19
03/21
16:31
03/21/19
16:31
Hot Stocks
Manitowoc settles action seeking damages for trade secret misappropriation »

The Manitowoc Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
03/21/19
03/21
16:30
03/21/19
16:30
Options
Preliminary option volume of 20.3M today »

Preliminary option volume…

CEO

Cnooc

$180.04

1.415 (0.79%)

16:29
03/21/19
03/21
16:29
03/21/19
16:29
Downgrade
Cnooc rating change at CLSA »

Cnooc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRZN

Horizon Technology

$12.55

0.22 (1.78%)

16:24
03/21/19
03/21
16:24
03/21/19
16:24
Syndicate
Horizon Technology files to sell 2M shares of common stock »

The joint-lead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLGL

Sol-Gel Technologies

$7.00

(0.00%)

16:22
03/21/19
03/21
16:22
03/21/19
16:22
Earnings
Sol-Gel Technologies reports FY18 loss $32.2M versus $31.6M last year »

Reports FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

  • 04

    Apr

DCP

DCP Midstream

$33.96

0.835 (2.52%)

16:20
03/21/19
03/21
16:20
03/21/19
16:20
Initiation
DCP Midstream initiated at Mizuho »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

16:20
03/21/19
03/21
16:20
03/21/19
16:20
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike down 3.4% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

CTAS

Cintas

$208.00

2.78 (1.35%)

16:20
03/21/19
03/21
16:20
03/21/19
16:20
Hot Stocks
Cintas reports Q3 organic revenue growth up 6% »

Reports Q3 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.